0001437749-23-028074.txt : 20231011
0001437749-23-028074.hdr.sgml : 20231011
20231011214202
ACCESSION NUMBER: 0001437749-23-028074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231001
FILED AS OF DATE: 20231011
DATE AS OF CHANGE: 20231011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 231321636
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-10-01
0001851657
Vaxxinity, Inc.
VAXX
0001377247
Powchik Peter
505 ODYSSEY WAY
MERRITT ISLAND
FL
32953
1
0
Stock option (right to buy)
1.27
2023-10-02
4
A
0
159744
0
A
Class A common stock
159744
159744
D
These options were granted following the Reporting Person joining the Issuer's leadership team as Executive Vice President, Global Scientific Director, effective October 1, 2023, while remaining a member of the Issuer's board of directors.
These options vest in 12 equal monthly installments beginning on October 1, 2023.
These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.
/s/ Rene Paula Molina, attorney-in-fact for Peter Powchik
2023-10-11